corilagin has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Lin, W; Liu, D; Proksch, P; Yu, S | 1 |
Su, J; Wei, D; Zhai, Q | 1 |
Bag, P; Das, S; Dave, P; Kumar, A; Mullick, R; Nandhitha, M; Reddy, BU; Roy, CL; Sharma, G; Shukla, A; Srinivasan, N; Srinivasan, P; Sudha, G; Tandon, H | 1 |
1 review(s) available for corilagin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Recent advancement in small molecules as HCV inhibitors.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; RNA | 2022 |
2 other study(ies) available for corilagin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Inhibitory effects of polyphenols toward HCV from the mangrove plant Excoecaria agallocha L.
Topics: Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Euphorbiaceae; Hepatitis C; Humans; Molecular Conformation; Polyphenols; RNA, Viral; Structure-Activity Relationship; Viral Nonstructural Proteins | 2012 |
A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cells, Cultured; Disease Models, Animal; Gene Expression; Genes, Reporter; Glucosides; Hepacivirus; Hepatitis C; Humans; Hydrolyzable Tannins; Liver; Liver Cirrhosis; Mice; NADPH Oxidase 4; Oxidative Stress; Plant Extracts; Rats; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta; Viral Nonstructural Proteins; Virus Replication | 2018 |